CRANBURY, NJ., April 25, 2018 – Solco Healthcare is proud to announce the launch of Entecavir Tablets, 0.5mg and 1mg, a generic equivalent of Baraclude® Tablets by Bristol-Myers Squibb Company. Solco is offering Entecavir Tablets, 0.5mg and 1mg, in 30-count bottles to its customers. The product is available for shipment immediately. Entecavir tablets are used to treat chronic hepatitis B virus infection in adults and children at least 2-year of age.
"We are excited to add Entecavir tablets to our growing product offerings. Solco has a longstanding commitment to expanding affordable access to treatments for patients who need them”, said Hai Wang, President of Solco Healthcare.
According to IQVIA, U.S. brand and generic combined sales of Entecavir tablets were approximately $91.8 million for the 12 months ending in February 2018.